A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.
Saved in:
| Title: | A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis. |
|---|---|
| Authors: | Green JR; Department of Gastroenterology, City General Hospital, Stoke-on-Trent, UK., Mansfield JC, Gibson JA, Kerr GD, Thornton PC |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2002 Jan; Vol. 16 (1), pp. 61-8. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Print ISSN: 0269-2813 (Print) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0269-2813 |
|---|---|
| DOI: | 10.1046/j.1365-2036.2002.01150.x |
